Eli Lilly will soon bring a pill version to the market, with a version expected to debut at a lower price than injectable ...

The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for ...

However, a proportion of the estimated 1.5 million people in the UK who are now on these jabs will struggle to keep the ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

When you hear the name Ozempic, you likely think of diabetes treatment. That makes sense, as semaglutide was first approved in 2017 to help people with type 2 diabetes regulate […] ...

GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

The appetite-suppressing medications reduce consumption of processed and sugary foods, creating new risks and opportunities.

What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...

GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.

LipoVive offers a safer, research-backed alternative, supporting metabolic balance, curbing cravings, and promoting steady ...

Thirty-nine percent of millennials and 35% of Gen Z say access to weight loss drugs would improve their job satisfaction or ...